Exactly, no way they can sell 3mg/kg regimen at the same price as 10mg/kg. Basically 3 possible results:
1. BMY don't seek approval for 10mg/kg combination regimen. $120k for 3mg/kg regimen, whoever uses off label dosage regimen pays more.
2. $120k for 3mg/kg regimen for now, reprice when 10mg/kg regiment is approved, thus effectively reduce price tag for 3mg/kg regimen.
3. Keep pricing as it is even after 10mg/kg regimen is approved, 10mg/kg would cost $400k.
Let's see how this plays out.
Market Data 
Markets 
AI
